Skip to main content

GREFI, Gynecology, Reproductive Endocrinology & Fertility Institute

San Juan, PR

Medical director: Rosa Ileana Cruz, MD

Outcomes — CDC ART 2022

155 total ART cycles reported.

Patient ageLive birth rate per intended retrievalEstimated retrievals to live birth
Under 3526.3%~3.8
35–3716.0%~6.3
38–409.7%~10
Over 400.0%

Cumulative success rate for patients using their own eggs (with or without prior ART cycles). Estimated retrievals = 1 / live birth rate (independence assumption — real-world outcomes vary with embryo banking and protocol changes). Source: CDC NASS ART Summary (2022).

Clinic information

Address
First Bank Building, 1519 Ponce de León Ave, Suite 705, San Juan 909
Phone
(787) 984-3008
CDC Clinic ID
145
Status
Open

Source: CDC National ART Surveillance System (NASS) Final ART Summary 2022.

Published pricing

GREFI, Gynecology, Reproductive Endocrinology & Fertility Institute does not publish itemized IVF pricing on its public website. Pricing is typically disclosed by a financial counselor after consultation. Typical US clinic range: $14,000–$30,000 per cycle plus medication.GREFI's official website (grefipr.org) was located and contains service/treatment pages, but no publicly accessible pricing, fees, or financial information page was found. All numeric price figures encountered in search results originated from third-party aggregator sites (e.g., Blooming Eve, Nicelocal) and were excluded per sourcing rules.

Cycle characteristics

Retrievals with no eggs collected
8.3%
Cycles discontinued before transfer
7.6%
Cycles for fertility preservation
1.9%
Transfers using a gestational carrier
0.0%
Frozen embryo transfers
19.8%
Transfers using ICSI
64.1%
Transfers using PGT
0.0%

Services offered

  • Donated embryo services
  • Egg cryopreservation
  • Embryo cryopreservation
  • SART member clinic

Patient infertility causes (CDC reported)

Causes can overlap — patients may report more than one. Percentages do not sum to 100%.

Tubal factor
39%
Male factor
31%
Unexplained
15%
Diminished ovarian reserve
8%
Endometriosis
5%
Other (infertility)
5%
Recurrent pregnancy loss
2%
Ovulatory dysfunction
1%
Other (non-infertility)
1%